All posts
-
Zealand Pharma nominates UCB veteran for its board of directors
Iris Loew-Friedrich belonged to UCB’s exec board from 2008 to 2024.
-
Genmab CEO points to Epkinly data as main event of the year
First-line therapy will possibly open a substantial market. Epkinly is currently accepted for DLBCL individuals that have actually gotten 2 or even more therapies.
-
Zealand Pharma expects new research center in Boston commisioned by summer
The proving ground intends to increase the biotech business’s medicine r & d.
-
Money earmarked for new Zealand Pharma partnerships – expects more deals signed soon
The coming duration will certainly see even more collaborations for the Danish biotech business and a concentrated initiative on automation and AI.
-
Zealand Pharma explores opportunities in weight-loss pill market
Novo Nordisk and Eli Lilly are concentrating on tablet computer variations of GLP-1 medicines. Zealand Pharma is taking a various strategy with amylin.
-
Leo Pharma expects margin shortfall, owners maintain 2026 IPO ambitions
Leo Pharma’s owners remain optimistic about a potential IPO in 2026, despite the company not expecting to reach its target of a minimum 20% earnings margin this year.
-
Recording webinar ‘From strategy to working capital optimisation’
Organisations yap regarding approach, development and consumer assurance. However inevitably, that approach is mirrored in stock and as a result in functioning funding on the annua…
-
Final Chance to Enter eVTOL Insights’ Global AAM Awards! Only One Week Left Until Entry Deadline
There is currently just one week left up until the due date for eVTOL Insights’ International AAM Honors, with firms wishing to participate requiring to send entrances no beh…
-
C&A optimises omnichannel operations with Nedap
C&A is optimizing its omnichannel logistics. To this end, the style merchant has actually participated in a tactical collaboration with technology company Nedap The applicatio…
